Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2005-09-20
2005-09-20
Wilson, James O. (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S059000
Reexamination Certificate
active
06946443
ABSTRACT:
The invention concerns a biologically active material essentially comprising at least an insolubilized dextran derivative of general formula DMCaBbSUcSdand at least a growth factor having an activity on osteoarticular, dental and/or maxillofacial tissues, and the method for preparing same. The invention also concerns the uses of said biomaterial for preparing a repair or filing material, such as an implant, for osteoarticular, dental or maxillofacial applications and for preparing an orthopaedic, dental or maxillofacial prosthesis, and the prosthesis coated with said biologically active material.
REFERENCES:
patent: 2 722 982 (1990-06-01), None
patent: 2 644 066 (1999-09-01), None
patent: WO 89/12464 (1989-12-01), None
patent: WO 90/10456 (1990-09-01), None
patent: WO 95/2678 (1995-10-01), None
patent: WO 99/01143 (1999-01-01), None
International PCT Patent Application No. PCT/FR00/01603, filed Jun. 9, 2000, International Publication No. WO 00/76562 A1, published Dec. 21, 2000 (English Translation).
PCT International Search Report for International PCT Patent Application No. PCT/FR00/01603, filed Jun. 9, 2000, International Publication No. WO 00/76562 A1, published Dec. 21, 2000.
PCT Chapter II Demand (Avis Informant Le Deposant De La Communication De La Demande Internationale Aux Offices Designes) for International PCT Patent Application No. PCT/FR00/01603, filed Jun. 9, 2000, International Publication No. WO 00/76562 A1, published Dec. 21, 2000.
Notification of Countries Elected (Informations Relatives Aux Offices Elus Qui Ont Recu Notification De Leur Election) for International PCT Patent Application No. PCT/FR00/01603, filed Jun. 9, 2000, International Publication No. WO 00/76562 A1, published Dec. 21, 2000.
Notification of Change of Applicant (Notification De L'Enregistrement D'Un Changement) for International PCT Patent Application No. PCT/FR00/01603, filed Jun. 9, 2000, International Publication No. WO 00/76562 A1, published Dec. 21, 2000.
PCT Preliminary International Examination Report (Rapport D'Examen Preliminaire International) for International PCT Patent Application No. PCT/FR00/01603, filed Jun. 9, 2000, International Publication No. WO 00/76562 A1, published Dec. 21, 2000.
Abstract: Japanese Application No. 04075920 filed Feb. 28, 1992, Publication No. 05238930 published Sep. 17, 1993 of Eisai Co., Ltd., pertains to a Long-Acting Medicine.
Publication: “In vitro relase characteristics of bioactive molecules from dextran dialdehyde cross-linked gelatin hydrogel films” by Jean-Pierre Draye, Bernard Delaey, Andre Van de Voorde, An Van Den Bulcke, Bogdan Bogdanov, and Etienne Schacht of Ghent, Belgium, Biomaterials published byElsevier Science, Ltd.1998.
Blanchat Cinderella
Chaubet Frederic
Correia Jose
Jozefonvicz Jacqueline
Jozefowicz Marcel
Biodex
Krishnan Ganapathy
Tolpin Thomas W.
Welsh & Katz Ltd.
Wilson James O.
LandOfFree
Biomaterial based on an insolubilized dextran derivative and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Biomaterial based on an insolubilized dextran derivative and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biomaterial based on an insolubilized dextran derivative and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3368372